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Snoring is now seen as one end of sleep-related breathing disorder resulting ultimately in obstructive 
sleep apnea. Uvulopalatopharyngoplasty (UPPP) is the first surgical procedure specifically designed to 
alleviate the abnormalities, although the use of laser appears to be the new trend. We present a case of 
Obstructive Sleep Apnoea (OSA) in an overweight young adult male which was corrected with the 
traditional UPPP. This paper also highlights the role of high index of suspicion and meticulous clinical 
decision making in the absence of sophisticated sleep studies.  
Introduction 
 
Obstructive sleep apnoea (OSA) is defined as the 
presence of 30 or more apnoeic episodes in a 7 
hour of sleep or apnoeic index greater than 5 per 
hour, with persistent respiratory effort1,2,3. 
Estimated prevalence rate is 2% in women and 
4% in men in the U.S.A3. 
 
Snoring is the noise produced during sleep as a 
result of partial upper airways obstruction1. It 
occurs in all age groups, but in general, 10% of 
men under the age of 30 years and 60% over 60 
years snore1. It is reported in 24% of men and 
14% of women among Italians. OSA is reported 
in 0.3% of men in the 35 – 65 years age group in 
the U.S.A2,3. 
 
The aetiopathology of OSA is poorly understood. 
The peak of presentation in children is about the 
age of five years and this is attributed to lymphoid 
hyperplasia involving the Waldeyer’s ring4. The 
documented risk factors for OSA are obesity with 
body weight greater than 15% of the ideal, male 
sex, craniofacial skeletal abnormalities and 
adenotonsillar hypertrophy. Moreover, alcohol 
and sedatives are known to aggravate OSA3-5 
 
Therapy for snoring and obstructive sleep apnea 
can range from the simple and inexpensive life 
style changes, continuous positive airway 
pressure to surgery. Surgery is a last resort option 
when snoring and apnoeic attacks are particularly 
severe5-8. Various procedures have been reported 
in the treatment of OSA. These include 
tonsillectomy, which is the commonest 
procedure1,4. Others are adenoidectomy; 
advancement of the tongue or mandibular bones; 
surgical correction of septal deviation, turbinate 
hypertrophy or nasal polyps; somnoplasty, and 
life saving tracheostomy when other treatments 
have failed4,5,6. 
 
The multiplicity of these options may suggest that 
success is not full proof in many cases and this 
may be related to the aetiopathology being poorly 
understood. Uvulopalatoplasty (UPPP) as a 
surgical treatment of OSA is rarely indicated. It 
involves tonsillectomy, partial resection of the 
anterior and posterior faucial pillars, soft palate 
and uvula. It was done by dissection, which was 
the traditional method, although in recent times 
the use of laser (Laser assisted uvelopalatoplasty) 
is the trend. We present here the report of a 30-
year-old man with OSA managed with UPPP by 




The patient was a 30-year-old unemployed 
Nigerian male with 9-years history of recurrent 
relapsing schizophrenia being managed in the 
psychiatric unit with anti-pyschotic drugs 
including haloperidol, trifluoperazine and 
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chlorpromazine. The psychiatrists admitted him 4 
weeks earlier for treatment of an acute episode of 
schizophrenia and disturbed sleep pattern. He was 
then referred to the otorhinolaryngology unit for 
progressively worsening snoring, nasal 
obstruction and apnoeic attacks during sleep. The 
airway obstruction had become so severe within 2 
weeks that the patient was dependent on 
oropharyngeal airway for most of the day and 
throughout the night (figure1). He was diagnosed 
with systemic hypertension 18 months before 
presentation and the blood pressure was 
controlled with oral Nifedipine and Moduretic.  
  Examination revealed an obese man in 
respiratory distress, sweating with noisy breathing 
that could be heard 20 metres from his bed. He 
was 1.9m in height and weighed 102kg with a 
body mass index (BMI) of 28.3kg/m2 .  
Oral examination revealed an enlarged and 
elongated uvula, which flapped between the 
nasopharynx and oropharynx with respiratory 
efforts, moderately enlarged Tonsils and weak 
redundant soft palate and faucial pillars. Figure 1 
shows Picture showing the patient in supine 
position with oropharyngeal airway insitu. Figure 
2 shows Picture of the patient seen in the out-
patient Clinic two weeks after surgery.  
 
 






















































Pre-operative Chest and neck radiographs, the 
electrocardiogram and full blood counts (FBC) 
were normal. The patient was prepared for UPPP 
with adequate counseling and consent for a 
tracheostomy if necessary. The anti hypertensive 
drugs and trifluperazine were continued till the 
day of surgery. No premedication drug was 
administered. He was transported to the operating 
theatre in a semi-recumbent position. Preparations 
made for difficult airway management included 
availability of different sizes of endotracheal 
tubes, bougies, long blade laryngoscopes and a 
tracheostomy set. 
 
Following administration of 0.6mg of Atropine, 
anaesthesia was induced using the inhalational 
technique with 50% oxygen (02 ) in nitrous oxide 
(N2O) and incremental concentrations of 
halothane.  Ventilation was manually checked and 
found adequate with no airway obstruction.  Then 
the anaesthesia was deepened with intravenous 
Thiopentone 200mg and suxamethonium 150mg 
was administered to aid endotracheal intubation.  
The airway was secured with an 8.0mm 
orotracheal tube and the patient was manually 
ventilated via a Bain circuit with a gas flow rate 
of 8L/min.  The anaesthesia was maintained with 
1-2% Isoflurane and 50% O2 in N2O.  Muscle 
relaxation was maintained with Pancuronium 7mg 
and pentazocine 60mg was administered for 
analgesia.  Intraoperative monitoring included 
non-invasive blood pressure measurement, ECG 
and O2 saturation. 
 
Examination under anaesthesia (EUA) of the 
nose, nasopharynx and direct Laryngoscopy 
showed no narrowing or mass lesion in the nose 
and larynx. Examination of the preoperative 
oropharynx confirmed the oral findings above. 
The site of obstruction was thus confirmed 
clinically to be the oropharynx and the pathology 
was velopharyngeal incompetence. He had UPPP 
i.e. tonsillectomy, partial resection of the anterior 
posterior faucial pillars, soft palate and uvula. The 
upper parts of the anterior and posterior faucial 
pillars were repaired on each side. 
 
Post operatively, the patient was able was able to 
breathe without the use of the oropharyngeal 
airway (Figure2). There was significant 
improvement of the snoring and complete 
cessation of the apnoeic episodes. He was 
discharged home for outpatient follow up on the 





In our patient, velopharyngeal incompetence 
(VPI) was the main cause of snoring, while 
another contributing factor was the overweight 
(BMI=28.3). In VPI, obstruction occurs when the 
increased negative intraluminal pressure is greater 
than the ability of the dilator to hold the pharynx 
open2. The resultant prolonged hypoxia and 
frequent arousal from sleep may present with 
multiple clinical problems such as systemic 
hypertension and social embarrassment  as 
presented in this patient. Other problems are 
marital problems, impotence, daytime 
hypersomnolence, road traffic accident and 
cardiac arrhythmias2,8. 
 
UPPP as a surgical treatment for OSA was first 
reported by Ikematsu and later modified and 
popularized by Fugital2. The goal of the surgery is 
to increase the cross sectional area of the 
velopharynx thus decreasing the airway 
resistance, eliminating the turbulent airflow and 
vibration responsible for collapse of the pharynx 
and snoring. The perioperative management of 
such patients should involve a high degree of 
clinical suspicion, control of airway throughout, 
judicious use of medications and appropriate 
monitoring10.  
 
UPPP is not a widely practiced surgical option in 
the management of OSA because of its limited 
effectiveness and the multi-factorial cause of 
OSA. Predicting which patient will benefit from it 
is often difficult3. Identification of the level of 
obstruction is crucial to the outcome of the 
surgery; this often needs a sleep endoscopy study 
or a polysomnography11 which was not done in 
this patient because it was not available in our 
hospital. We accept this as a drawback in the 
diagnosis of this case. 
 
In spite of this, our clinical assessment was 
strongly suggestive of velopharyngeal 
incompetence, hence the indication for surgery. 
Conservative management was not considered 
because of the severity of snoring and airway 
obstruction which was confirmed by the far 
distance from which the snoring could be heard as 
well as dependence on oropharyngeal airway two 
weeks prior to surgery. Additional reasons are co-
morbidity factors such as poor mental health, 
possibility of non-compliance, particularly as the 
patient was on anti-psychotic drugs to control the  
 
 




schizophrenia. Although there was pain 
postoperatively, other complications namely 
Velopharygeal incompetence and hypernasal 
speech were not seen in the patient; however the 
patient is still being followed up. 
 
The cessation of apnoea, independence of 
oropharyngeal airway and remarkable 
improvement in snoring postoperatively were the 
indices of the successful outcome of surgery 
(Figure 2). The reported success rate of UPPP in 
curing snoring is 80 – 90% and 50 – 60% for 
OSA 2.  
  
In conclusion, UPPP as a surgical option for the 
treatment of OSA has been beneficial for our 
patient. Therefore, it remains a useful therapeutic 
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